(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.21%) $11.02
(0.56%) $0.808
(-0.95%) $93.01
Live Chart Being Loaded With Signals
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers...
Stats | |
---|---|
Today's Volume | 137 793 |
Average Volume | 50 544.00 |
Market Cap | 0.00 |
EPS | $0 ( 2023-03-27 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.0760 (15.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-18 | Martell Bridget A | Buy | 0 | |
2023-10-18 | Orbach Pini | Buy | 0 | |
2023-10-18 | Golan Roy | Buy | 0 | |
2023-01-19 | Amoon Growth Fund Limited Partnership | Sell | 2 991 473 | Common Stock |
2023-01-19 | Sidransky David | Sell | 12 500 | Stock Option (right to buy) |
INSIDER POWER |
---|
-97.35 |
Last 84 transactions |
Buy: 4 327 382 | Sell: 8 482 924 |
Volume Correlation
Ayala Pharmaceuticals Inc Correlation
10 Most Positive Correlations | |
---|---|
SPCB | 0.933 |
MERC | 0.928 |
ATER | 0.927 |
YELL | 0.923 |
STAF | 0.922 |
CSSE | 0.922 |
SISI | 0.922 |
VCSA | 0.921 |
ASPS | 0.916 |
PASG | 0.915 |
10 Most Negative Correlations | |
---|---|
SCPL | -0.914 |
CBAY | -0.912 |
HEES | -0.91 |
JMPNZ | -0.907 |
TWCB | -0.906 |
MSDA | -0.901 |
THCP | -0.901 |
ZING | -0.9 |
ROC | -0.899 |
AEAE | -0.898 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Ayala Pharmaceuticals Inc Correlation - Currency/Commodity
Ayala Pharmaceuticals Inc Financials
Annual | 2022 |
Revenue: | $692 000 |
Gross Profit: | $90 000.00 (13.01 %) |
EPS: | $-2.46 |
Q4 | 2022 |
Revenue: | $105 000 |
Gross Profit: | $-38 000.00 (-36.19 %) |
EPS: | $-0.620 |
Q3 | 2022 |
Revenue: | $91 000.00 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.660 |
Q2 | 2022 |
Revenue: | $38 000.00 |
Gross Profit: | $-7.80M (-20 531.58 %) |
EPS: | $-0.540 |
Financial Reports:
No articles found.
Ayala Pharmaceuticals Inc
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, a potent, selective, and oral small molecule GSI that is in Phase II/III pivotal study for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators